Study of hepatoprotective effects of xymedon

dc.contributor.author	Vyshtakalyuk A.
dc.contributor.author	Nazarov N.
dc.contributor.author	Zueva I.
dc.contributor.author	Lantsova A.
dc.contributor.author	Minnekhanova O.
dc.contributor.author	Busygin D.
dc.contributor.author	Porfiryev A.
dc.contributor.author	Evtyugin V.
dc.contributor.author	Reznik V.
dc.contributor.author	Zobov V.
dc.date.accessioned	2018-09-18T20:02:25Z
dc.date.available	2018-09-18T20:02:25Z
dc.date.issued	2013
dc.identifier.issn	0007-4888
dc.identifier.uri	https://dspace.kpfu.ru/xmlui/handle/net/135979
dc.description.abstract	Xymedon (1-(β-oxyethyl)-4,6-dimethyl-1,2-dihydro-2-oxopyrimidine), a regeneratory and wound-healing drug, exhibited hepatoprotective activity in laboratory animals with experimental toxic hepatitis. Oral drug reduced the severity of toxic involvement of the liver induced by CCl4 and reduced animal mortality. Xymedon promoted recovery of the blood biochemical parameters characterizing the liver status. © 2013 Springer Science+Business Media New York.
dc.relation.ispartofseries	Bulletin of Experimental Biology and Medicine
dc.subject	hepatic diseases
dc.subject	hepatoprotectors
dc.subject	toxic hepatitis
dc.subject	xymedon
dc.title	Study of hepatoprotective effects of xymedon
dc.type	Article
dc.relation.ispartofseries-issue	5
dc.relation.ispartofseries-volume	155
dc.collection	Публикации сотрудников КФУ
dc.relation.startpage	643
dc.source.id	SCOPUS00074888-2013-155-5-SID84885236946

Файлы в этом документе

Размер: 44.21Kb

Формат: PDF

Публикации сотрудников КФУ Scopus [24551]
Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.